Predicate |
Object |
contentType |
Journal Article |
endingPage |
7 |
issn |
1179-1365 |
pageRange |
163-7 |
publicationName |
Drug, Healthcare and Patient Safety |
startingPage |
163 |
bibliographicCitation |
Norgard NB, Badgley BT. Profound thrombocytopenia after primary exposure to eptifibatide. Drug Healthc Patient Saf. 2010;2():163–7. PMID: 21701628; PMCID: PMC3108691. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_185b3f1b76a3fe643a0a90845fdf725f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_025473dff8d2291a3c0ffd22bbf8897b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4612-0107 |
date |
201009 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/21701628 https://pubmed.ncbi.nlm.nih.gov/PMC3108691 https://doi.org/10.2147/dhps.s13239 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/38653 https://portal.issn.org/resource/ISSN/1179-1365 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Profound thrombocytopenia after primary exposure to eptifibatide |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448812 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11015 |